Skip to main content
Equibles

FMR LLC

Position in GPCR — Structure Therapeutics Inc.

CIK 315066 BOSTON, MA
Back to GPCR Full portfolio

Position in GPCR

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$419,179,120
+$14,132,880 QoQ
Shares Held
7,810,306
-7.1% QoQ
Ownership
11.0%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#1
of 190 holders
Holding Since
Mar 2023
14 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in GPCR Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

FMR LLC holds $61,908,415,112 across 370 Biotechnology names. GPCR ranks #37 (0.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ARGX
Argenx SE
 5,231,452 $4,853,584,218
2 ALNY
Alnylam Pharmaceuticals, Inc.
 15,023,962 $4,522,663,276
3 MRNA
Moderna, Inc.
 51,859,891 $3,631,748,165
4 ROIV
Roivant Sciences Ltd.
 81,020,390 $2,867,311,601
5 RVMD
Revolution Medicines, Inc.
 12,200,422 $2,284,895,029
6 IONS
Ionis Pharmaceuticals Inc
 24,631,956 $1,953,067,789
7 INSM
INSMED Inc
 16,143,583 $1,721,228,815
8 KRYS
Krystal Biotech, Inc.
 4,418,197 $1,642,111,277

All Filings in GPCR

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $419,179,120 7,810,306
2026-03-31 $405,046,240 8,403,449
2025-12-31 $605,937,054 8,712,251
2025-09-30 $147,010,304 5,250,368
2025-06-30 $101,936,372 4,914,965
2025-03-31 $101,846,966 5,883,707
2024-12-31 $164,855,589 6,078,746
2024-09-30 $268,977,404 6,128,444
2024-06-30 $225,598,646 5,744,809
2024-03-31 $126,384,023 2,948,764
2023-12-31 $164,449,642 4,034,584
2023-09-30 $80,184,689 1,590,335
2023-06-30 $51,452,643 1,237,735
2023-03-31 $29,723,844 1,249,426